Global HEOR Strategy Lead Evidence for Access (E4A), Immunology, Specialty Care
Sanofi
Summary
This role will work within the Global E4A team for the next-gen immunology franchise, focusing on an early pipeline portfolio and working cross-functionally to shape the HEOR evidence foundation of the early pipeline spanning multiple early-stage assets and disease areas.
Job description
Main Responsibilities
This role will work within the Global E4A team for the next-gen immunology franchise, focusing on an early pipeline portfolio and working cross-functionally to shape the HEOR evidence foundation of the early pipeline spanning multiple early-stage assets and disease areas.
Epidemiology & Disease Landscape
- Lead epidemiology assessments across immunology disease areas of interest characterizing disease burden, natural history, prevalence/incidence, and unmet need to inform early asset strategy
- Translate HEOR insights into actionable input for target product profiles, value propositions and to inform potential differentiation
Early IEGP Shaping & Evidence Strategy
Work cross functionally to integrate payer needs into Integrated Evidence Generation Plans (IEGPs) for pipeline assets ensuring global and country stakeholder input is reflected into fit for purpose plans.
Real World Insights
- Generate and apply real-world insights (observational data, natural history studies, treatment pattern analyses) to inform early pipeline strategy, disease understanding, and future evidence needs
- Lead early differentiation assessments using Indirect Treatment Comparisons (ITCs), network meta-analyses, and other relevant methodologies to benchmark emerging assets against the evolving competitive and standard-of-care landscape
- Continuously monitor the competitive immunology landscape to refresh differentiation assessments as new data emerges
- Lead the development and communication of disease level evidence including real world insights and evidence, economic models, HTA landscape assessments to inform trial design including PRO/ClinPRO, endpoints and comparator selection
Clinical Development Plan Input
- Partner with clinical development teams as part of a multi-functional global team to inform clinical trial design, including endpoint selection, comparator choice, and patient population definition, to meet the evidentiary standards of regulators, HTA organizations and payers
- Provide HEOR and real-world input into protocol development and clinical trial design discussions for early pipeline assets
- Keep current with emerging innovative HEOR methodologies for application into day to day work
Cross-Functional Partnership
- Serve as a subject matter expert providing input to commercial, medical, clinical development, and market access teams on early pipeline evidence strategy
- Build strong cross-functional relationships across Research, Clinical Development, Medical Affairs, Market Access, and Commercial to ensure evidence strategy is embedded early and consistently across functions
- Anticipate communication needs across cross-functional audiences and pre-empt issues with timely and effective action
Requirements
- 6+ years of experience in health economics, outcomes research, or a related field
- Advanced degree (e.g. PhD, MD, MS, MPH, or PharmD) in a relevant discipline
- Strong communication skills, both verbal and written
- Established track record of scientific and/or methods publications in peer-reviewed journals
- Strong ability to partner with HEOR colleagues and other (i.e. non-HEOR) functional areas
- Entrepreneurial, team spirit and ability to develop creative solutions to complex problems
- Demonstrated experience in applying various HEOR methods
- Understanding the principles of evidence-based medicine and clinical research
- Knowledge of global HTA processes and guidelines
- Strong understanding of real-world evidence generation methodologies and epidemiology
- Experience with Indirect Treatment Comparisons (ITCs), network meta-analyses, or other comparative effectiveness approaches
- Understanding of the legal and regulatory environment of the pharmaceutical industry
- English fluent, both written and oral
- Compliance with all relevant internal SOPs and external laws and regulations
Benefits
- Health Insurance
- Prevention & Wellness Programs
- Gender-Neutral Parental Leave
- Rewards Package
Company overview
Sanofi is a French multinational pharmaceutical and healthcare company headquartered in Paris, France. Founded in 1973, the company has grown through strategic mergers and acquisitions to become one of the world's leading pharmaceutical corporations. Sanofi operates as an R&D-driven, AI-powered biopharma company committed to improving people's lives through breakthrough science. The company's portfolio spans seven major therapeutic areas including cardiovascular diseases, diabetes, oncology, immunology, rare diseases, neurology, and vaccines. Through its subsidiary Sanofi Pasteur, it is the world's largest producer of vaccines. Sanofi employs over 84,000 people across more than 100 countries and maintains a significant presence in both developed and emerging markets. The company's innovative pipeline focuses on advancing precision medicines and biologics while maintaining a strong commitment to sustainability and ethical business practices. Sanofi's mission centers on chasing the miracles of science to deliver transformative healthcare solutions globally.